Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM

Overactivity of the hexosamine pathway mediates glucose-induced insulin resistance in rat adipocytes. Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limiting enzyme of this pathway. We determined GFA activity in human skeletal muscle biopsies and rates of insulin-stimulated whole-body, oxidative, and nonoxidative glucose disposal using the euglycemic insulin clamp technique combined with indirect calorimetry (insulin infusion rate (1.5 mU · kg−1 · min−1) in 12 male patients with NIDDM (age 54 ± 2 years, BMI 27.5 ± 0.9 kg/m2, fasting plasma glucose 8.5 ± 0.6 mmol/l) and 9 matched normal men. GFA activity was detectable in human skeletal muscles and completely inhibited by uridine-5′-diphospho-N-acetylglucosamine (UDP-GlcNAc) in all subjects. GFA activity was 46% increased in the NIDDM patients compared with the normal subjects (9.5 ± 1.3 vs. 6.5 ± 1.2 pmol, P < 0.05). Whole-body glucose uptake was 58% decreased in patients with NIDDM (20 ± 3 μmol · kg body wt−1 · min−1) compared with normal subjects (47 ± 4 μmol · kg body wt−1 · min−1 P < 0.001). This decrease was attributable to decreases in both glucose oxidation (9 ± 1 vs. 15 ± 1 μmol · kg−1 · min−1, NIDDM patients vs. control subjects, P < 0.002) and nonoxidative glucose disposal (11 ± 2 vs. 31 ± 4 μmol · kg−1 · min−1 P < 0.001). In patients with NIDDM, both HbA1c (r = 0.51, P < 0.05) and BMI (r = −0.57, P < 0.05) correlated with whole-body glucose uptake. HbA1c but not BMI or insulin sensitivity was correlated with basal GFA activity (r = −0.57,P < 0.01) in NIDDM patients and control subjects. We conclude that GFA is found in human skeletal muscle and that all this activity is sensitive to feedback inhibition by UDP-GlcNAc. Chronic hyperglycemia is associated with an increase in skeletal muscle GFA activity, suggesting that increased activity of the hexosamine pathway may contribute to glucose toxicity and insulin resistance in humans.

[1]  P. Scheinberg,et al.  THE CEREBRAL BLOOD FLOW IN MALE SUBJECTS AS MEASURED BY THE NITROUS OXIDE TECHNIQUE. NORMAL VALUES FOR BLOOD FLOW, OXYGEN UTILIZATION, GLUCOSE UTILIZATION, AND PERIPHERAL RESISTANCE, WITH OBSERVATIONS ON THE EFFECT OF TILTING AND ANXIETY. , 1949, The Journal of clinical investigation.

[2]  R. Kornfeld.  Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. , 1967, The Journal of biological chemistry.

[3]  S. Shimojyo,et al.  Total cerebral blood flow and metabolism in human brain stem disease. , 1968, Neurology.

[4]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[5]  B. Desbuquois,et al.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. , 1971, The Journal of clinical endocrinology and metabolism.

[6]  M. Roth.  Fluorescence reaction for amino acids. , 1971, Analytical chemistry.

[7]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[8]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[9]  D. Sonneborn,et al.  Developmentally regulated interconversions between end product-inhibitable and noninhibitable forms of a first pathway-specific enzyme activity can be mimicked in vitro by protein dephosphorylation-phosphorylation reactions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Taskinen,et al.  Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. , 1984, The Journal of clinical endocrinology and metabolism.

[11]  H. Yki-Järvinen,et al.  Natural course of insulin resistance in type I diabetes. , 1986, The New England journal of medicine.

[12]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[13]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[14]  H. Yki-Järvinen,et al.  Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. , 1988, The American journal of medicine.

[15]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[16]  S. Marshall,et al.  Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. , 1989, The Journal of biological chemistry.

[17]  M. Taskinen,et al.  Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. , 1989, American Journal of Physiology.

[18]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[19]  L. Mandarino,et al.  Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical investigation.

[20]  K. Sahlin,et al.  Localization of Rate-Limiting Defect for Glucose Disposal in Skeletal Muscle of Insulin-Resistant Type I Diabetic Patients , 1990, Diabetes.

[21]  R. Henry,et al.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. , 1990, The Journal of clinical investigation.

[22]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[23]  P. O'Hara,et al.  Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase. , 1992, The Journal of biological chemistry.

[24]  U Ruotsalainen,et al.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. , 1992, The Journal of clinical investigation.

[25]  A. Paterson,et al.  Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Paterson,et al.  Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway. , 1993, Molecular endocrinology.

[27]  J. Viikari,et al.  Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. , 1993, The American journal of physiology.

[28]  M. Buse,et al.  Pre-Exposure to Glucosamine Induces Insulin Resistance of Glucose Transport and Glycogen Synthesis in Isolated Rat Skeletal Muscles: Study of Mechanisms in Muscle and in Rat-1 Fibroblasts Overexpressing the Human Insulin Receptor , 1993, Diabetes.

[29]  D. McClain,et al.  Regulation of Insulin-Stimulated Glycogen Synthase Activity by Overexpression of Glutamine: Fructose-6-Phosphate Amidotransferase in Rat-1 Fibroblasts , 1993, Diabetes.

[30]  M. Mueckler.  Facilitative glucose transporters. , 1994, European journal of biochemistry.

[31]  U. Ruotsalainen,et al.  Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. , 1994, The Journal of clinical investigation.

[32]  H. Lebovitz,et al.  Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive? , 1995, Diabetes.

[33]  D. McClain,et al.  Regulation of Glycogen Synthase by Glucose, Glucosamine, and Glutamine:Fructose-6-Phosphate Amidotransferase , 1995, Diabetes.